In this Expert Interview, Dr. Andrew D. Seidman critically appraises the latest data, addresses the controversies, and opines about adjuvant systemic therapy for breast cancer. Medscape Hematology-Oncology
Determining the correct dosage for chemotherapeutic agents presents a challenge because there is a fine balance between doses that cause significant drug toxicity and loss of efficacy. Nature Clinical Practice Oncology
Middle- and higher-density single-nucleotide polymorphism (SNP) arrays detect more chronic lymphocytic leukemia (CLL) lesions than lower-density arrays. Medscape Medical News
